Corrigendum: Transcervical Foley Balloon Plus Vaginal Misoprostol versus Vaginal Misoprostol Alone for Cervical Ripening in Nulliparous Obese Women: A Multicenter, Randomized, Comparative-Effectiveness Trial

The author would like to update the results of the above article published online in the American Journal of Perinatology on April 16, 2020 (DOI: 10.1055/s-0040-1708805) in issue number 38, volume S1. It was brought to the author's attention that 14 duplicate subjects were inadvertently included in the initial trial analysis. These have now been removed and study and data were reanalyzed. There were no significant changes to the primary outcome. Demographic characteristics and secondary outcomes were updated as shown in [Tables 1] [2] [3] [4].

Table 1 Baseline clinical characteristics

	Combined (N = 108)	PGE1 (N = 114)
Age (years)	25.3 ± 5.8	24.1 ± 5.4
Gestational age (weeks)	38.7 ± 1.8	38.5 ± 1.6
Ethnicity
African American	24 (22)	25 (22)
Caucasian	14 (13)	14 (12)
Hispanic	65 (60)	67 (59)
Other	5 (1)	8 (1)
Married	61 (56)	63 (55)
Prenatal care	105 (97)	113 (99)
Government/Subsidized insurance	59 (55)	65 (57)
Hypertensive disease	57 (53)	60 (53)
Diabetes in pregnancy	15 (14)	23 (20)
Body Mass Index (kg/m2)	38.7 ± 7.5	37.6 ± 7.2
Bishop Score	3 [2–4]	3 [2–5]

Data presented as N (%), mean ± standard deviation or median (Interquartile Range [IQR]).

Abbreviation: PGE1, Prostaglandin E1 (Misoprostol).

Table 2 Indications for induction of labor

	Combined (N = 108)	PGE1 (N = 114)
Hypertensive disorders	38 (35.2)	36 (31.6)
Gestational age ≥40 weeks	21 (19.4)	8 (7.0)
Elective	15 (13.9)	26 (22.8)
Oligohydramnios	8 (7.4)	12 (10.5)
Gestational diabetes	5 (4.6)	14 (12.3)
Other[a]	21 (19.4)	18 (15.8)

Data presented as N (%).

^a Abnormal antenatal testing, growth restriction, and cholestasis of pregnancy.

Table 3 Indications for cesarean delivery

	Combined (N = 51)	PGE1 (N = 51)	p- Value
Arrest disorders[a]	31 (60.8)	27(52.9)	0.67
Nonreassuring Fetal heart rate tracing	13 (25.5)	15 (29.4)	0.74
Other[b]	7 (13.7)	9 (17.6)	0.64

Data presented as N (%).

^a Failed induction, failure to progress.

^b Cord prolapse, compound presentation.

Table 4 Relevant secondary outcomes

	Combined (N = 108)	PGE1 (N = 114)	p-Value
Composite maternal morbidity	6 (5.5)	4 (3.5)	0.48
Intensive care unit admission	–	3 (2.6)
Endometritis	3 (2.8)	–
Surgical site infection	3 (2.8)	1 (0.9)
Composite neonatal morbidity	11 (10.2)	9 (7.9)	0.59
Apgar score < 7 at 5 minutes	3 (2.8)	3 (2.6)
Cord pH < 7.1	5 (4.6)	5 (4.4)
Any neonatal injury	3 (2.8)	3 (2.6)[a]

Data presented as N (%).

^a Same neonate had more than one adverse outcome.

Publikationsverlauf

Accepted Manuscript online:
21. Februar 2024

Artikel online veröffentlicht:
10. April 2024